Exploring the therapeutic potential of Caralluma fimbriata for antioxidant and diabetes management: a 28-day rat model study.
Arif A, Sultan MT, Nazir F, Ahmad K, Kashif M, Ahmad MM, Shehzad FK, Nazir MA, Mushtaq S, Khalid MU, Noman AM, Raza H, Israr M, Sohail H, Rocha JM.
Arif A, et al.
Toxicol Res (Camb). 2024 Jul 1;13(4):tfae094. doi: 10.1093/toxres/tfae094. eCollection 2024 Aug.
Toxicol Res (Camb). 2024.
PMID: 38957782
This study evaluated the anti-oxidant and anti-diabetic potential of Caralluma fimbriata (CF) in 28-days rat modelling trial. Diabetes is a chronic disorder characterized by elevated blood glucose levels and insulin resistance and cause microvascular and macrovascul …
This study evaluated the anti-oxidant and anti-diabetic potential of Caralluma fimbriata (CF) in 28-days rat modelling trial. …